| 0.19 Data as of 10:07am ET |  +0.0299 / +18.68%Today’s Change | 0.01 Today|||52-Week Range 0.25 | +11.83% Year-to-Date |
| Previous close | 0.16 |
| Today’s open | 0.19 |
| Day’s range | 0.19 - 0.19 |
| Volume | 800 |
| Average volume (3 months) | 24,112 |
| Market cap | $5.7M |
| Dividend yield | -- |
| Earnings growth (last year) | +45.00% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +50.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 31.57 |
| Price/Book | 4.84 |
| No competitors data available. |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $146.0K |
| Annual profit (last year) | -$3.8M |
| Net profit margin | -2,604.79% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President & Chief Executive Officer James M. Frincke, PhD |
CFO, Secretary & Head-Investor Relations Robert W. Weber, MBA |
Corporate headquarters San Diego, California |
.
